AAPL   383.68 (+0.25%)
MSFT   213.67 (-0.30%)
FB   245.07 (+0.23%)
GOOGL   1,539.01 (+1.34%)
AMZN   3,200.00 (+0.55%)
NVDA   419.17 (-0.28%)
MU   50.70 (+1.44%)
GE   6.69 (+1.67%)
TSLA   1,544.65 (+10.78%)
AMD   55.88 (-2.41%)
T   30.13 (+2.00%)
ACB   12.02 (+2.12%)
F   6.10 (+4.27%)
GILD   76.32 (+2.15%)
DIS   119.34 (+2.16%)
BAC   24.02 (+5.49%)
NFLX   548.73 (+8.07%)
AAPL   383.68 (+0.25%)
MSFT   213.67 (-0.30%)
FB   245.07 (+0.23%)
GOOGL   1,539.01 (+1.34%)
AMZN   3,200.00 (+0.55%)
NVDA   419.17 (-0.28%)
MU   50.70 (+1.44%)
GE   6.69 (+1.67%)
TSLA   1,544.65 (+10.78%)
AMD   55.88 (-2.41%)
T   30.13 (+2.00%)
ACB   12.02 (+2.12%)
F   6.10 (+4.27%)
GILD   76.32 (+2.15%)
DIS   119.34 (+2.16%)
BAC   24.02 (+5.49%)
NFLX   548.73 (+8.07%)
AAPL   383.68 (+0.25%)
MSFT   213.67 (-0.30%)
FB   245.07 (+0.23%)
GOOGL   1,539.01 (+1.34%)
AMZN   3,200.00 (+0.55%)
NVDA   419.17 (-0.28%)
MU   50.70 (+1.44%)
GE   6.69 (+1.67%)
TSLA   1,544.65 (+10.78%)
AMD   55.88 (-2.41%)
T   30.13 (+2.00%)
ACB   12.02 (+2.12%)
F   6.10 (+4.27%)
GILD   76.32 (+2.15%)
DIS   119.34 (+2.16%)
BAC   24.02 (+5.49%)
NFLX   548.73 (+8.07%)
AAPL   383.68 (+0.25%)
MSFT   213.67 (-0.30%)
FB   245.07 (+0.23%)
GOOGL   1,539.01 (+1.34%)
AMZN   3,200.00 (+0.55%)
NVDA   419.17 (-0.28%)
MU   50.70 (+1.44%)
GE   6.69 (+1.67%)
TSLA   1,544.65 (+10.78%)
AMD   55.88 (-2.41%)
T   30.13 (+2.00%)
ACB   12.02 (+2.12%)
F   6.10 (+4.27%)
GILD   76.32 (+2.15%)
DIS   119.34 (+2.16%)
BAC   24.02 (+5.49%)
NFLX   548.73 (+8.07%)
Log in

NASDAQ:PRTKParatek Pharmaceuticals Earnings Date, Estimates & History

$5.22
-0.15 (-2.79 %)
(As of 07/10/2020 04:00 PM ET)
Add
Compare
Today's Range
$5.13
Now: $5.22▼
$5.40
50-Day Range
$4.22
MA: $4.75▼
$5.52
52-Week Range
$2.50
Now: $5.22▼
$5.89
Volume333,450 shs
Average Volume750,201 shs
Market Capitalization$225.15 million
P/E RatioN/A
Dividend YieldN/A
Beta1.53

Earnings

Paratek Pharmaceuticals (NASDAQ:PRTK) Earnings Information

Paratek Pharmaceuticals last announced its earnings results on May 11th, 2020. The specialty pharmaceutical company reported ($0.66) earnings per share for the quarter, topping analysts' consensus estimates of ($0.80) by $0.14. The company earned $7.92 million during the quarter, compared to analyst estimates of $7.75 million. Paratek Pharmaceuticals has generated ($3.93) earnings per share over the last year. Paratek Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 4th, 2020 based off prior year's report dates.

Paratek Pharmaceuticals Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Paratek Pharmaceuticals (NASDAQ:PRTK) Earnings Estimates

2020 EPS Consensus Estimate: ($2.33)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20201($0.91)($0.91)($0.91)
Q2 20202($0.14)$0.21$0.04
Q3 20202($0.71)($0.70)($0.71)
Q4 20202($0.75)($0.74)($0.75)

Paratek Pharmaceuticals (NASDAQ PRTK) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
8/4/2020
(Estimated)		       
5/11/20203/31/2020($0.80)($0.66)($0.66)$7.75 million$7.92 millionListen
2/25/2020Q4 2019($1.03)($0.81)($0.81)$4.78 million$8.97 millionTranscript
11/12/2019Q3($1.06)($1.00)($1.00)$3.63 million$3.93 millionTranscript
8/6/2019Q2 2019($1.16)($1.02)($1.02)$1.86 million$2.05 millionTranscript
5/8/20193/31/2019($1.19)($1.10)($1.10)$0.89 million$1.60 millionN/A
2/27/2019Q4 2018($0.65)($0.71)($0.71)$16.50 million$17.02 millionN/A
11/6/2018Q3($0.85)($1.01)($1.01)$5.89 million$0.05 millionN/A
8/2/2018Q2 2018($0.92)($0.94)($0.94)$0.10 million$0.04 millionN/A
5/9/2018Q1($0.94)($0.91)($0.91)$0.02 million$0.01 millionTranscript
3/1/2018Q4 2017($0.75)($0.7840)($0.78)$5.00 million$5.07 millionN/A
11/8/2017Q3 2017($0.93)($0.77)($0.77)$0.01 millionN/A
8/2/2017Q2 2017($0.89)($0.64)($0.62)$7.50 million$7.51 millionListen
5/4/2017Q1 2017($1.2010)($1.14)($1.14)$0.02 millionListen
3/2/2017Q4 2016($1.29)($1.16)($1.16)$0.03 millionListen
11/2/2016Q3 2016($1.38)($1.04)($1.04)N/A
8/4/2016Q2 2016($1.66)($1.69)($1.69)N/A
5/2/2016Q1 2016($1.18)($1.78)($1.78)N/A
2/23/2016Q4 2015($1.40)($1.17)($1.14)Listen
11/12/2015Q3 2015($0.91)($1.33)($1.33)Listen
8/5/2015Q2 2015($0.75)($0.94)($0.92)$3.62 billionN/A
5/15/2015Q1 2015($2.16)($0.96)($1.18)N/A
4/2/2015Q1($2.16)($0.74)$0.13 million$4.00 millionN/A
5/5/2014Q1 2014($1.80)($1.80)$0.42 millionN/A
3/13/2014Q4 2013($2.64)($3.48)($3.48)$0.50 million$0.32 millionN/A
11/7/2013Q3 2013($2.52)($3.00)($3.00)$0.10 million$0.38 millionN/A
8/7/2013Q2 2013($3.48)($2.40)($0.48)$0.20 millionN/A
5/8/2013Q1 2013($5.04)($6.72)($6.72)($5.83) millionTranscript
2/27/2013Q4 2012($3.12)($4.20)($4.20)N/A
11/12/2012Q312$0.06$0.25$8.37 million$10.44 millionListen
8/13/2012Q2 2012($3.60)($3.60)($3.60)N/A
5/14/2012Q1 2012($5.28)($4.47)($4.47)N/A
3/14/2012Q4 2011$4.20$4.42$4.42N/A
11/10/2011Q3 2011($4.92)($4.43)($4.43)N/A
8/11/2011Q2 2011($3.36)($2.04)($2.04)N/A
5/16/2011Q1 2011($3.24)($1.68)($1.68)N/A
3/16/2011Q4 2010($3.36)($2.35)($2.35)N/A
11/11/2010Q3 2010($2.64)($2.47)($2.47)N/A
8/9/2010Q2 2010($1.80)($1.85)($1.85)N/A
5/12/2010Q1 2010($2.04)($1.66)($1.66)N/A
3/23/2010Q4 2009($2.76)($2.11)($2.11)N/A
11/12/2009Q3 2009($0.12)($3.47)($3.47)N/A
8/14/2009Q2 2009($6.53)($6.53)N/A
5/13/2009Q1 2009($11.38)($11.38)N/A
3/23/2009Q4 2008($15.71)($8.26)N/A
11/10/2008Q3 2008($15.97)($15.97)N/A
5/12/2008Q1 2008($13.21)($2.76)($2.76)N/A
3/17/2008Q4 2007($5.40)($6.24)($6.24)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 7/10/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.